Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 452 results found. Search for [ coronavirus vaccine developed in India ]

Results 40 to 60 of 452
BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


PTI
November 16, 2020
Speaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for COVID-19 which would be in the form of nasal drops and can be ready by next year


Aseem Thapliyal
November 15, 2020
Over the past week, the 30-share BSE Sensex jumped 1,744.92 points or 4.16 per cent


PTI
November 15, 2020
The Coastal Shipping Bill, 2020, which proposes to do away with the requirement of trading licence for Indian flag vessels for coastal trade has been circulated for inter-ministerial consultation


BusinessToday.In
November 15, 2020
As per Anthony Fauchi, the Pfizer's vaccine distribution process in the US will start in December. This, he said, will also help reduce the daily spike in coronavirus cases, which reached 1.9 lakh this week


BusinessToday.In
November 12, 2020
US-based Moderna Inc has claimed that it has sufficient data for a first interim analysis of the advanced-phase trial of its COVID-19 vaccine candidate, which should help ascertain the inoculation's efficacy


Anwesha Madhukalya
November 12, 2020
Nirmala Sitharaman press conference: The minister said that the Rs 900 crore funding to the Department of Biotechnology will be for research purposes only


BusinessToday.In
November 12, 2020
Pfizer COVID-19 vaccine would need to be stored at -70 degree Celsius, which experts believe, would be a daunting challenge even for the best medical centres


BusinessToday.In
November 11, 2020
Russia coronavirus vaccine: The interim trial results were announced by Russia's sovereign wealth fund Russian Direct Investment Fund on Wednesday. RDIF is backing the vaccine and marketing it globally


BusinessToday.In
November 11, 2020
COVAXIN's phase-3 trial at AMU is aimed at checking the safety and effectiveness of the COVID-19 vaccine, jointly developed by the Hyderabad-headquartered Bharat Biotech, National Institute of Virology (NIV) and Indian Council of Medical Research (ICMR)


BusinessToday.In
November 11, 2020
Share of Pfizer gained 3.76% to Rs 5238 against previous close of Rs 5048 on BSE


BusinessToday.In
November 11, 2020
The major hurdle for the vaccine is storage and distribution. Pfizer's COVID-19 vaccine candidate needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below


BusinessToday.In
November 11, 2020
Coronavirus vaccine: India will focus on these two vaccines as they are being tested on the Indian population and hence has a major advantage over other potential candidates


Reuters
November 10, 2020
Enough people would be vaccinated by April-May, so that the fight against the pandemic in Spain would move to another stage


PTI
November 10, 2020
They reported the design of a 'heat-tolerant' COVID-19 vaccine candidate and a rapid method to identify specific regions on the HIV envelopeprotein that are targeted by antibodies, which can help design effective vaccines


BusinessToday.In
November 10, 2020
Share of Pfizer gained 19.46% to touch record high of Rs 5875 against previous close of Rs 4917 on BSE


BusinessToday.In
November 10, 2020
India Stock Market Highlights Today: ICICI Bank followed by ONGC, HDFC, L&T, SBI, HDFC Bank, IndusInd Bank and Bajaj Finance were among the top gainers on Sensex today. On the other hand, Tech Mahindra, Infosys, HCL Tech, TCS, Nestle India and Maruti were in the red


PTI
November 6, 2020
The World Economic Forum (WEF) said the latest survey has shown a growing reluctance to receive a vaccine, despite progress made by numerous pharmaceutical companies working on vaccine trials


BusinessToday.In
November 5, 2020
The Hyderabad-based company that has developed COVAXIN with Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), had hoped to roll it out in the second quarter of 2021


BusinessToday.In
November 5, 2020
Coronavirus vaccine update: Data compiled by Duke Global Health Innovation Center said that India has pre-ordered 600 million doses of coronavirus vaccine and is now in the process of negotiation for additional 1 billion doses


PAGES 3 OF 23  12345